To evaluate the contribution of the assessment of endothelial dysfunction (ED) in improving coronary hearth disease (CHD) risk stratification obtained by the Framingham risk score (FRS) in rheumatoid arthritis population (RA).
ED, determined by peripheral arterial tonometry (PAT), will be evaluated at baseline in 3000 RA patients free of previous cardiovascular events. Incident CHD events during the 3-year planned follow-up will be registered. A measure of the incremental yield of ED will be obtained comparing 2-year Framingham risk score for CHD (FRS) and FRS plus ED differential prognostic performances by C-statics and risk reclassification analysis.
Study Type
OBSERVATIONAL
Enrollment
3,000
Endothelial dysfunction will be measured assessing reactive hyperemia of digital arteries by using Endo-PAT2000 (Itamar, Israel).
Policlinico Universitario di Monserrato Azienda Ospedaliera Universitaria di Cagliari
Monserrato, Cagliari, Italy
RECRUITINGComplesso Integrato Columbus, UO di Reumatologia
Roma, Roma, Italy
RECRUITINGAzienda Ospedaliero Universitaria di Sassari, UOC di Reumatologia
Sassari, Sassari, Italy
RECRUITINGCHD events
The following events will be considered as incident CHD events: myocardial infarction, CHD death, resuscitated cardiac arrest, or definite or probable angina if followed by coronary revascularization.
Time frame: 3 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.